Pfizer Share Price

Pfizer Share Price

NSE: PFIZER
|
Pharmaceuticals
₹ 4,593.30
+₹15.40 (0.34%)
1D
Last updated 21 Jul, 2026, 15:47 IST

Pfizer Share Price Today

As of 21 Jul 2026, Pfizer share price is ₹4,593.30. The stock opened at ₹4,567.10, compared to its previous close of ₹4,577.90. During today's trading session, Pfizer share price moved in the range of ₹4,545.90 to ₹4,600.00, with an average price of ₹4,572.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹4,360.10 and a high of ₹5,873.50. On the performance front, Pfizer share price has declined by 0.37% over the last six months and is down 13.89% on a year-on-year basis.

₹4,545.90
0.34% up today
₹4,600.00
1D LOW
1D HIGH

Pfizer Returns Calculator

Open
₹4,567.10
High
₹4,600.00
Low
₹4,545.90
Prev. close
₹4,577.90
Circuit
L
H
₹3,662.40
₹5,493.40
52-week
L
H
₹4,360.10
₹5,873.50

Pfizer Shareholder Returns

Pfizer Share Price History

Mkt Cap Cr
1,394.87
P/E
29.89
P/B
5.14
ROE
19.78%
D/E
0.02
ROCE
27.27%
Div. Yield
1.59%
EPS(TTM)
157.92
Turnover
0.59
EV/EBITDA
17.79
Net Margin
28.67%
Op. Margin
41.39%
ROA
33.25%
Quick Ratio
5.31
Curr. Ratio
6.23
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Pfizer outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Pfizer appears to be fairly valued compared to its peers
Step 1 of 5
Earnings
Very Poor
Pfizer revenue, operating profits and net profits have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,69,382.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,94,375.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,69,333.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,16,447.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Zydus Lifesciences1,14,379.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,13,316.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,05,979.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories1,02,106.0024.972.7511.64%0.1513.65%3.320.64%0.6338.68
Aurobindo Pharma90,637.0025.882.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs84,235.7060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

Pfizer Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsNov 2006Nov 2007Nov 2008Nov 2009
Revenue769.81,019.76982.61867.69
Operating profit162.64451.34419.13210.01
Net profit106.33340299.58137.12

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,519.65₹2,281.35₹2,193.17₹2,424.76
Other Income₹187.95₹172.25₹180.51₹101.05
Total Revenue₹2,707.60₹2,453.60₹2,373.68₹2,525.81
Total Expenses₹1,682.77₹1,610.32₹1,635.56₹1,734.80
Profit Before Tax₹975.67₹1,016.09₹746.07₹824.01
Tax₹253.24₹248.49₹194.74₹200.08
Profit After Tax₹722.43₹767.60₹551.33₹623.93
EPS - Basic₹157.92₹167.79₹119.22₹136.38
EPS - Diluted₹157.92₹167.79₹120.51₹136.38

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹975.67₹1,016.09₹746.07₹824.01
Income before WC changes₹912.85₹770.52₹656.75₹692.75
Change in Assets-₹12.27₹7.23-₹89.91₹85.03
Change in Liabilities₹52.46₹38.22-₹156.18-₹119.52
Change in WC₹40.19₹45.45-₹246.09-₹34.49
Cash flow from Operations₹967.57₹659.75₹256.84₹355.68
Cash flow from Investing-₹561.67-₹71.34₹53.70-₹36.05
Cash flow from Financing-₹798.31-₹205.34-₹235.14-₹345.79
Total Cash Flow-₹392.41₹383.07₹75.40-₹26.16
Cash (Start of the year)₹495.07₹112.00₹36.60₹62.76
Cash (End of the year)₹102.66₹495.07₹112.00₹36.60

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,118.66₹1,398.26₹1,490.97₹1,475.64
Current Assets₹3,803.22₹3,512.85₹2,737.81₹2,525.09
Total Assets₹4,921.88₹4,911.11₹4,228.78₹4,000.73
Current Liabilities₹627.48₹569.51₹546.56₹657.35
Net Current Asset₹3,175.74₹2,943.34₹2,191.25₹1,867.74
Non-Current Liabilities₹91.50₹124.19₹86.68₹136.08
Equity Capital₹4,202.90₹4,217.41₹3,595.54₹3,207.30
Total Equity & Liabilities₹4,921.88₹4,911.11₹4,228.78₹4,000.73
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
4593.3
6
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 6
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
49.18
Neutral
ATR (14)
98.72
Neutral
STOCH(9,6)
28.16
Neutral
STOCH RSI (14)
33.44
Neutral
ADX(9)
23.52
Bearish
UO(9)
47.58
Neutral
ROC(12)
3.12
Bullish
WillR(14)
-55.84
Neutral
Period
Simple value
Exponential vaue
5D
4642.34
4621.18
10D
4634.03
4617.22
20D
4558.6
4592.66
50D
4595
4610.09
100D
4706.57
4684.03

About Pfizer

Pfizer Share Price
ISIN
INE182A01018
Sector Market Cap
₹ 1,394.87 Cr

Pfizer Limited (Pfizer) is an India-based multinational pharmaceutical company focusing on therapy in four business categories, namely, Vaccines, Hospitals, Internal Medicine, and Inflammation and Immunology. Pfizer’s Vaccines Division focuses on Prevenar 13, a Pneumococcal Conjugate Vaccine approved for administering to individuals of all ages against pneumococcal disease, an infection caused by streptococcus pneumoniae bacteria. Internal Medicine portfolio includes approximately 17 specialties and seven therapy areas, including respiratory, multivitamin and multimineral, gastrointestinal, pain, neuroscience, cardiovascular and women’s healthcare. Pfizer Hospital Business Unit focuses on providing advanced anti-infectives to institutions such as hospitals and nursing homes. Inflammation and Immunology focuses on discovering and developing novel therapeutics for chronic autoimmune diseases. Its brands include Prevenar13, CorexDX, Dolonex, Enbrel, Becosules and Folvite, among others.

Pfizer Financial Highlights

  • Revenue: Pfizer reported revenue of ₹867.69 crore in FY09 vs ₹982.61 crore in FY08. It showed a decrease of 11.70% on a yearly basis.
  • Operating Profit: Pfizer reported an operating profit of ₹210.01 crore in FY09 vs ₹419.13 crore in FY08. It showed a decrease of 49.89% on a year-on-year basis.
  • Net Profit: Pfizer reported a net profit of ₹137.12 crore in FY09 vs ₹299.58 crore in FY08. It showed a decrease of 54.23% on a yearly basis.

Pfizer Quarterly Result Highlights

  • Pfizer reported revenue of ₹669.95 crore in Mar 2026, compared with ₹683.24 crore in Dec 2025, representing a decrease of 1.95% on a quarter-on-quarter (QoQ) basis.
  • Pfizer reported an operating profit of ₹268.82 crore in Mar 2026, compared with ₹191.95 crore in Dec 2025, representing an increase of 40.05% on a quarter-on-quarter (QoQ) basis.
  • Pfizer reported a profit of ₹199.82 crore in Mar 2026, compared with ₹141.84 crore in Dec 2025, reflecting an increase of 40.88% on a QoQ basis.
  • The earnings per share (EPS) of Pfizer stood at ₹157.92 during Mar 2026.
Know more
Promoters
63.92%
FII
1.65%
Other DII
5.12%
Retail and other
16.63%
Mutual funds
12.68%
Foreign institutions - FII
Compare against other stocks
Pfizer Share Price
Pfizer
Pharmaceuticals
Add Stock
Add Another

FAQs on Pfizer Share Price